These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18275900)

  • 1. Risk-adjusted outcome measurement in pediatric allogeneic stem cell transplantation.
    Matthes-Martin S; Pötschger U; Bergmann K; Frommlet F; Brannath W; Bauer P; Klingebiel T
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):335-43. PubMed ID: 18275900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
    Wang Y; Chen F; Han Y; Fu ZZ; Tang XW; Miao M; Qiu HY; Jin ZM; Sun AN; Wu DP
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1258-64. PubMed ID: 19747633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
    Kröger N; Zabelina T; Binder T; Ayuk F; Bacher U; Amtsfeld G; Lellek H; Schrum J; Erttmann R; Eiermann T; Zander A
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):454-62. PubMed ID: 19285633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Gratwohl A; Stern M; Brand R; Apperley J; Baldomero H; de Witte T; Dini G; Rocha V; Passweg J; Sureda A; Tichelli A; Niederwieser D;
    Cancer; 2009 Oct; 115(20):4715-26. PubMed ID: 19642176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and cost-effectiveness of allogeneic stem cell transplantation in children are predictable.
    Matthes-Martin S; Pötschger U; Barr R; Martin M; Boztug H; Klingebiel T; Attarbaschi A; Eibler W; Mann G
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1533-9. PubMed ID: 22484665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population.
    Pond GR; Lipton JH; Messner HA
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):422-9. PubMed ID: 16545726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.
    Schmid I; Stachel D; Pagel P; Albert MH
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemopoietic stem cell transplantation in childhood: reduction in mortality and improvement of survival over the years.
    Espigado I; Marín-Niebla A; Pérez-Hurtado JM; Ríos E; Carmona M; Plaza E; Vaquero A; Campo T; Pérez de Soto I; Martino ML; Parody R; Rodríguez-Fernández JM
    Transplant Proc; 2005 Apr; 37(3):1555-6. PubMed ID: 15866671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
    Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source.
    Barker JN; Hough RE; van Burik JA; DeFor TE; MacMillan ML; O'Brien MR; Wagner JE
    Biol Blood Marrow Transplant; 2005 May; 11(5):362-70. PubMed ID: 15846290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric standard-risk AML with fully matched sibling donors: to transplant in first CR or not?
    Gassas A; Afzal S; Ishaqi MK; Finkelstein-Shechter T; Rojas M; Dupuis A; Sung L; Doyle J
    Bone Marrow Transplant; 2008 Sep; 42(6):393-6. PubMed ID: 18587434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
    Ayuk F; Diyachenko G; Zabelina T; Wolschke C; Fehse B; Bacher U; Erttmann R; Kröger N; Zander AR
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):913-9. PubMed ID: 18640575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia.
    Jung AS; Holman PR; Castro JE; Carrier EK; Bashey A; Lane TA; Nelson CL; Pu M; Messer K; Corringham SM; Ball ED
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1306-13. PubMed ID: 19747639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of centre and period effects in allogeneic haematopoietic stem cell transplantation in France.
    Mesnil F; Jouet JP; Tuppin P; Vernant JP; Golmard JL
    Bone Marrow Transplant; 2004 Oct; 34(7):645-51. PubMed ID: 15300230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience.
    Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK
    Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
    Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M;
    J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.